Regeneron Pharmaceuticals, Inc.’s Stock Price Drops to $666.87, Reveals 2.02% Decrease: A Deep Dive into REGN Market Performance

Regeneron Pharmaceuticals, Inc. (REGN)

666.87 USD -13.74 (-2.02%) Volume: 1.31M

Regeneron Pharmaceuticals, Inc.’s stock price stands at 666.87 USD, experiencing a decline of -2.02% in the latest trading session with a trading volume of 1.31M, reflecting a year-to-date percentage change of -6.38%, showcasing an important aspect for investors considering REGN’s stock performance.

Latest developments on Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN) has been making headlines recently with a mix of positive and negative news affecting its stock price. From winning prestigious science awards like the Regeneron Science Talent Search to facing legal battles with Amgen over Eylea biosimilars, the company has been on a rollercoaster ride. Despite setbacks like the denial of a patent stay for Eylea, Regeneron’s stock price saw a 4.7% increase after an appeals court upheld a decision against the company. With major investors like Swiss National Bank selling shares and others like Machina Capital boosting their holdings, the future of Regeneron remains uncertain. Analysts like Jim Cramer remain bullish on the company, urging investors to stay the course.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma